Neuroendocrine tumors of the pancreas

Current Treatment Options in Gastroenterology

Volumn 7, Issue 5, 2004, Pages 355-364

  McLoughlin, James M ^a   Kuhn, Joseph A ^a   Lamont, Jeffrey T ^a  

^a General/Oncology Surgical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ATROPINE PLUS DIPHENOXYLATE; CISPLATIN; DIAZOXIDE; DIURETIC AGENT; DOXORUBICIN; ESOMEPRAZOLE; FLUOROURACIL; GLUCOCORTICOID; GLUCOSE; INDOMETACIN; IODINE 131; LANSOPRAZOLE; LONG ACTING DRUG; LOPERAMIDE; OCTREOTIDE; OMEPRAZOLE; PANTOPRAZOLE; PHENYTOIN; PREDNISONE; PROPRANOLOL; PROTON PUMP INHIBITOR; RABEPRAZOLE; STREPTOZOCIN; VERAPAMIL; YTTERBIUM;

ABDOMINAL CRAMP; ABDOMINAL PAIN; BIOCHEMISTRY; BODY WEIGHT DISORDER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CATHETERIZATION; CHEMOEMBOLIZATION; CONFUSION; COST EFFECTIVENESS ANALYSIS; CRYOSURGERY; DEEP VEIN THROMBOSIS; DIARRHEA; DISEASE COURSE; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MECHANISM; EARLY DIAGNOSIS; GALLSTONE FORMATION; HEADACHE; HUMAN; HYPOGLYCEMIA; IMAGING SYSTEM; INJECTION SITE; LEG EDEMA; LIVER METASTASIS; LIVER TOXICITY; METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUROENDOCRINE TUMOR; PAIN; PANCREAS CANCER; PEPTIC ULCER; REVIEW; STEATORRHEA; SUPERINFECTION; SYMPTOMATOLOGY; TACHYCARDIA; TASTE DISORDER; WEIGHT GAIN;

EID: 7944238393     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0048-7     Document Type: Review

References (43)

1. Delcore R, Friesen SR: Gastrointestinal neuroendocrine tumors. J Am Coll Surg 1994, 178:187.
2. Doherty GM, Olson JA, Frisella MM, et al.: Lethality of multiple endocrine neoplasia type 1. Wor Jour Surg 1998, 22:581-586.
3. Skogseid BS, Eriksson B, Lundqvist G, et al.: Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. Jr Clin Endo and Metabol 1991, 73: 81-287.
4. Kisker O, Batsch D, Weinel RJ, et al.: The value of somatostatin-receptor scintigraphy in newly diagnosed gastroenteropancreatic tumors. J Am Coll Surg 1997, 184: 87-492.
5. Machado MC, Jukemura J, Da Chunha JE, et al.: Surgical treatment of insulinoma: Study of 59 cases. Rev Assoc Med Bras 1998, 44:159-166.
6. Doherty GM: Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surg Onc 2003, 12:135-143.
7. Cohen MS, Picus D, Lairmore TC, et al.: Prospective study of provocative angiograms to localize functional islet cell tumors of the pancreas. Surgery 1997, 122:1091-1101.
8. Eriksson B, Skogseid B, Lundqvist G, et al.: Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer 1990, 65: 883-1890.
9. Mignon M, Ruszniewski P, Podevin P, et al.: Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. Wor J Surg 1993, 17: 89.
10. Perry RR, Vinik A: Endocrine tumors of the gastrointestinal tract. Annu Rev Med 1996, 47:57-68.
11. Norton JA, Jensen RT: Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN 1). Surg Onc 2003, 12:145-151.
12. Nor-ton JA, Fraker DL, Alexander HR, et al.: Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999, 341:635.
13. Weber HC, Venzon DJ, Lin JT, et al.: Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: A prospective long-term study. Gastroenterology 1995, 108: 637-1649.
14. Gibril F, Schumann M, Pace A, Jensen RT: Multiple Endocrine Neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 2004, 83:43-83.
15. Brentjens R, Saltz L: Islet cell tumors of the pancreas: The Medical Oncologist's Perspective. Surg Clin Nor Amer 2001, 81:527-542.
16. Uwaifo GI, Muzzammil A, Shoukri K, Whitaker-Worth DL: Diabetes but not psoriasis. Lancet 1999, 354:480.
17. Soga J, Yakuwa Y: Somatostatinoma/inhibitory syndrome: A statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999, 18: 3-22.
18. Gullo L, Migliori M, Falconi M, et al.: Nonfunctioning pancreatic endocrine tumors: a multicenter clinical study Amer Jour Gastroentero 2003, 98:2435-2439.
19. Jordan PH Jr: A personal experience with pancreatic and duodenal neuroendocrine tumors. J Am Coll Surg 1999, 189: 70-482.
20. Yim JH, Siegel BA, DeBenedetti MK, et al.: Prospective study of the utility of somatostatin receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1. Surgery 1998, 124:1037-1042.
21. Meko JB, Doherty GM, Siegel BA, et al.: Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors Surgery 1996, 120:975-984.
22. Anderson MA, Carpenter S, Thompson NW, et al.: Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Amer Jour Gastroentero 2000, 95:2271-2277.
23. Hiramoto JS, Feldstein VA, LaBerge IM, Norton JA: Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001, 136:1020-1026.
24. Aoki T, Sakon M, Ohzato H, et al.: Evaluation of preoperative and intraoperative arterial stimulation and venous sampling for diagnosis and surgical resection of insulinoma. Surgery 1999, 126:968.
25. Maton PA: The use of long acting somatostatin analogue, octreotide acetate in patients with islet cell tumors. Gastroenterol Clin North Amer 1989, 18:897-922.
26. Bewly AP, Ross JS, Bunker CB, et al.: Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema. Br J Dermatol 1996, 134:1101.
27. Azimuddin K, Chamberlain RS: The surgical management of pancreatic neuroendocrine tumors. Surg Clin Nor Amer 2001, 81:511-525.
28. Arnold R, Trammann ME, Creutzfeldt W, et al.: Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumors. Gut 1996, 38:430-438.
29. Kvols LK, Reubi JC, Horisberger U, et al.: The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med 1992, 65:505.
30. Lamberts SW, van der Lely AJ, de Herder WW, et al.: Octreotide. N Engl J Med 1996, 334:246-0.
31. Oberg K: Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Annals of Oncology 2001, 12(Suppl 2): 111-114.
32. Chatal JF, Le Bodic MF, Kraeber-Bodere F, et al.: Nuclear Medicine Applications for Neuroendocrine Tumors. World J Surg 2000, 24:1285-1289.
33. Shojamanesh H, Gibril F, Louie A, et al.: Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer 2002, 94:331-343.
34. Huai JC, Zhang W, Nitt HO, et al.: Localization and surgical treatment of pancreatic insulinomas guided by intraoperative ultrasound. Am J Surg 1998, 175:18.
35. Fraker DL, Norton JA, Alexander R, et al.: Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma Ann Surg 1994, 220:320-330.
36. Sarmiento JM, Farnell MB, Que FG, et al.: Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: Long-term survival analysis. World Jour Surg 2002, 26:1267-1271.
37. Simon D, Strake A, Goretzki PE, et al.: Reoperative surgery for organic hyperinsulinism: Indications and operative strategy World J Surg 1998, 22:666-671.
38. Hellman P, Ladjevardi S, Skogseid B, et al.: Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World Jour Surg 2002, 26:1052-1056.
39. Siperstein AE, Rogers SJ, Hansen PD, et al.: Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases Surgery 1997, 122:1147-1155.
40. Perry LJ, Stuart K, Stokes KR, et al.: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994, 116:1111-1117.
41. Ruszniewski P, Rougier F, Roche A, et al.: Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993, 71:2624-2630.
42. Broughan TA, Leslie JD, Soto JM, et al.: Pancreatic islet cell tumors. Surgery 1986, 99:671-678.
43. Hochwald SN, Zee S, Conlon KC, Colleoni R, et al.: Prognostic Factors in Pancreatic Endocrine Neoplasms: An analysis of 136 Cases with a proposal for low-grade and Intermediate-grade groups. Jour Clin Onc 2002, 20:2633-2642.